| Literature DB >> 35805505 |
Karina Pitombeira Pereira-Pedro1, Iris Machado de Oliveira2, Irimia Mollinedo-Cardalda2, José M Cancela-Carral1.
Abstract
(1) Background: Those with Parkinson's disease (PD) may present difficulties in performing dual tasks (DT). The use of DT during training can improve different abilities. Therefore, the objective of this study is to verify the influence of a cycling exercise program combined with a cognitive task on cognitive and physical PD aspects; (2)Entities:
Keywords: Parkinson’s disease; cognitive-motor interference; cycling; dual task
Mesh:
Year: 2022 PMID: 35805505 PMCID: PMC9266068 DOI: 10.3390/ijerph19137847
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Baseline demographics and clinical characteristics of the participants.
| Parkinson’s Disease | Experimental | Control | T Student | |
|---|---|---|---|---|
| Age (years) | 68.13 ± 7.82 | 70.50 ± 9.24 | 65.43 ± 5.22 | t = 1.280; |
| Gender (male/female) | 12/3 | 6/2 | 6/1 | - |
| Hoehn and Yahr stage | 2.33 ± 0.62 | 2.38 ± 0.74 | 2.29 ± 0.49 | t = 0.270; |
Cycling program physical parameters.
| Groups | T Student | ||
|---|---|---|---|
| Experimental | Control | ||
|
| 47,100 ± 31,400 | 76,910 ± 18,530 | t = 2.060; |
|
| 57,590 ± 23,930 | 34,800 ± 5,670 | t = 2.264; |
|
| 266.33 ± 176.13 | 418.82 ± 132.22 | t = 1.997; |
|
| 78.18 ± 41.85 | 119.26 ± 28.29 | t = 2.066; |
|
| 83.64 ± 22.02 | 80.03 ± 46.23 | t = 1.066; |
|
| 45.07 ± 25.98 | 64.30 ± 15.09 | t = 1.610; |
|
| 48.91 ± 22.36 | 52.15 ± 18.17 | t = 0.554; |
|
| 92.16 ± 3,85 | 92.12 ± 6.42 | t = 0.067; |
|
| 103.38 ± 3.30 | 118.10 ± 5.81 | t = 1.981; |
Obs. * p < 0.05.
Results on primary outcomes pre- and post-intervention.
| Experimental Group | Control Group | MANOVA | |||||
|---|---|---|---|---|---|---|---|
| Pre-Test | Post-Test | % Change | Pre-Test | Post-Test | % Change | ||
| Mean ± sd | Mean ± sd | Mean ± sd | Mean ± sd | ||||
|
| 20.66 ± 8.76 | 21.47 ± 10.50 | −3.92 | 12.05 ± 7.74 | 10.96 ± 7.33 | 9.05 | F1,23 = 0.120; |
|
| 20.05 ± 13.64 | 19.55 ± 27.34 | 2.50 | 12.36 ± 8.37 | 7.31 ± 5.16 | 59.14 | F1,23 = 2.062; |
|
| 18.53 ± 9.46 | 9.42 ± 10.40 | 50.38 | 10.43 ± 8.36 | 3.77 ± 2.69 | 64.95 | F1,23 = 0.002; |
|
| 12.53 ± 3.28 | 11.31 ± 6.06 | 9.74 | 10.49 ± 5.63 | 8.96 ± 3.37 | 58.59 | F1,23 = 0.004; |
|
| 14.22 ± 4.08 | 17.09 ± 9.93 | −20.18 | 12.32 ± 5.76 | 10.76 ± 3.87 | 12.66 | F1,23 = 0.004; |
|
| 14.49 ± 3.03 | 14.77 ± 6.73 | −1.93 | 12.38 ± 5.37 | 11.51 ± 3.72 | 7.03 | F1,23 = 0.005; |
|
| 11.50 ± 3.25 | 13.50 ± 3.16 | 17.39 | 14.14 ± 2.61 | 14.67 ± 3.67 | 3.75 | F1,23 = 0.691; |
Obs. PDQ, Parkinson´s disease quality of life questionnaire; MDS-UPDRS, Movement Disorder Society´s Unified Parkinson´s Disease Rating Scale; TUG, Timed Up and Go Test; * p < 0.05.
Results obtained at the cognitive level.
| Experimental Group 1 | Control Group | MANOVA | ||||||
|---|---|---|---|---|---|---|---|---|
| Pre-Test | Post-Test | % Change | Pre-Test | Post-Test | % Change | |||
| Mean ± sd | Mean ± sd | Mean ± sd | Mean ± sd | |||||
|
|
| 72.50 ± 12.08 | 71.63 ± 8.55 | 1.20 | 78.43 ± 17.45 | 81.33 ± 6.65 | −3.70 | F1,23 = 0.021; |
|
| 44.88 ± 12.05 | 48.25 ± 13.65 | −7.51 | 62.86 ± 9.35 | 61.00 ± 5.44 | 2.96 | F1,23 = 0.875; | |
|
| 25.50 ± 13.49 | 29.25 ± 13.64 | −14.71 | 32.00 ± 11.93 | 31.50 ± 7.69 | 1.56 | F1,23 = 0.286; | |
|
| 27.56 ± 6.19 | 26.95 ± 5.33 | 2.21 | 34.48 ± 5.17 | 34.82 ± 2.79 | −0.99 | F1,23 = 0.008; | |
|
| −2.06 ± 8.49 | 2.30 ± 12.08 | 211.65 | −2.48 ± 12.10 | −3.32 ± 6.31 | −33.87 | F1,23 = 0.373; | |
Obs. STROOP, Stroop Color-Word Test.